Getting the message about biobanking: returning to the basics

References

• Park A. 10 Ideas changing the world right now. Time Magazine. 2009. Available from: http://content.time.com/time/specials/packages/article/0,28804,1884779_1884782_1884766,00.html. Accessed November 2, 2016.
   Google Scholar
• Vaught J, Kelly A, Hewitt R. A review of international biobanks and networks: Success factor and key benchmarks. Biopreserv Biobank. 2010;7:143–150.
   Web of Science ®Google Scholar
• Beier K, Lenk C. Biobanking strategies and regulative approaches in the EU: recent perspectives. J Bioreposit Sci Appl Med. 2015;3:69–81.
   Google Scholar
• De Souza YG, Greenspan JS. Biobanking past, present and future: responsibilities and benefits. AIDS. 2013;27:303–312.
   PubMed Web of Science ®Google Scholar
• Chadwick D, Roehrl MHA. High-quality biobanking for personalised precision medicine: BioSpecimens at the helm. Diagn Histopathol. 2013;19:447–455.
   Google Scholar
• Pelagio G, Pistillo D, Mottolese M. Minimum biobanking requirements: issues in a comprehensive cancer centre biobank. Biopreserv Biobank. 2011;9:141–148.
   Web of Science ®Google Scholar
• Grizzle WE, Aamodt R, Clausen K, et al. Providing human tissue for research. Arch Pathol Lab Methods. 1998;122:1065–1076.
   PubMed Web of Science ®Google Scholar
• Esgueva R, Park K, Kim R, et al. Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium. Diagn Mol Pathol. 2012;21:61–68.
   Google Scholar
• Mee B, Gaffney E, Glynn SA, et al. Development and progress of Ireland’s Biobank Network: ethical, legal, and social implications (ELSI), standardized documentation, sample and data release, and international perspective. Biopreserv Biobank. 2013;11:3–11.
   Web of Science ®Google Scholar
• Hewitt RE. Biobanking: the foundation of personalized medicine. Curr Opin Oncol. 2010;23:112–119.
   Web of Science ®Google Scholar
• Lochmüller H, Aymé S, Pampinella F, et al. The role of biobanking in rare diseases: European Consensus Expert Group report. Biopreserv Biobank. 2010;7:155–156.
   Google Scholar
• Graham CE, Molster C, Baynam GS, et al. Current trends in biobanking for rare diseases: a review. J Bioreposit Sci Appl Med. 2014;2:49–61.
   Google Scholar
• Mora M, Angelini C, Bignami F, et al. The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases. Eur J Hum Genet. 2014;272:1–8.
   Google Scholar
• Riegman PHJ, van Veen E-B. Biobanking residual tissues. Hum Genet. 2011;130:357–368.
   Web of Science ®Google Scholar
• Brisson AR, Matsui D, Rieder MJ, et al. Translational research in pediatrics: tissue sampling and biobanking. Pediatrics. 2011;129:153–162.
   Web of Science ®Google Scholar
• Zatloukai K, Hainaut P. Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine. Future Med. 2010;4:895–903.
   Google Scholar
• Basik M, Aguilar-Mahecha A, Rouseau C, et al. Biopsies: next generation biospecimens for tailoring therapy. Nat Rev Clin Oncol. 2013;10:437–450.
   PubMed Web of Science ®Google Scholar
• Herpel E, Rocken C, Manke H, Schirmacher P, Flechtenmacher C. Quality management and accreditation of research tissue banks: experience of the National Center for Tumour Diseases (NCT) Heidelberg. Virchows Arch. 2010;457:741–747.
   Web of Science ®Google Scholar
• Riegman PHJ, de Jong BWD, Llombart-Bosch A. The Organisation of European Cancer Institute Pathobiology Working Group and its support of European biobanking infrastructure for translational cancer research. Cancer Epidemiol Biomarkers Prev. 2010;19:923–926.
   Google Scholar
• Vegvari A, Welinder C, Lindberg H, Fehniger TE, Marko-Varga G.. Biobank resources for future patient care: developments, principles and concepts. J Clin Bioinforma. 2011;1:24.
   PubMedGoogle Scholar
• Goldblatt EM, Lee W-H. From bench to bedside: the growing use of translational research in cancer medicine. Am J Transl Res. 2010;2:1–18.
   PubMed Web of Science ®Google Scholar
• Dancey J. Genomics, personalized medicine and cancer practice. Clin Biochem. 2012;45:379–381.
   Web of Science ®Google Scholar
• McKeon S. McKeon review: we need to integrate research and health services. Transforming the Nation’s Healthcare website. 2012 October. Available from: http://www.transformingthenation.com.au/2012/10/mckeon-review-we-need-to-integrate-research-and-health-services/. Accessed November 2, 2016.
   Google Scholar
• NSW government response to the NSW health and medical research strategic review. NSW Government Ministry of Health website; 2012. Available from: http://www.health.nsw.gov.au/ohmr/Publications/stratreview-gov-response.pdf. Accessed November 2, 2016.
   Google Scholar
• Boyer GJ, Whipple W, Cadigan RJ, Henderson GE. Biobanks in the United States: how to identify an undefined and rapidly evolving population. Biopreserv Biobank. 2012;10:511–517.
   Web of Science ®Google Scholar
• National Health and Medical Research Council, Biobank Information Paper, 2010. Available from: https://www.nhmrc.gov.au/guidelines-publications/e110. Accessed November 2, 2016.
   Google Scholar
• Hewitt R, Hainaut P. Biobank is a fast moving world: an international perspective. J Natl Cancer Inst Monogr. 2011;42:50–51.
   Google Scholar
• Consistent State-wide Consent for Research Biobanking Consultation Paper. NSW Health Pathology website. 2015 March. Available from: http://www.health.nsw.gov.au/ohmr/biobankregistry/Documents/biobank-consent-public-consultation.pdf. Accessed November 2, 2016.
   Google Scholar
• Hewitt R, Watson P. Defining biobank. Biopreserv Biobank. 2011;11:309–315.
   Web of Science ®Google Scholar
• Carpenter J, Clarke CL. Biobanking sustainability – Experiences of the Australian Breast Cancer Tissue Bank (ABCTB). Biopreserv Biobank. 2014;12:395–401.
   Web of Science ®Google Scholar
• Catchpoole DR. Biohoarding: treasures not seen, stories not told. J Health Serv Res Policy. 2015;21:140–142.
   Web of Science ®Google Scholar
• Knoppers BM, Avard D, Senecal K. Newborn screening programmes: emerging biobanks? Norsk Epidemiologi. 2012;21:163–168.
   Google Scholar
• Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J. 2007;30:373–382.
   PubMed Web of Science ®Google Scholar
• Kaye J. Do we need uniform regulatory system for biobanks across Europe. Eur J Hum Genet. 2006;14:245–248.
   Web of Science ®Google Scholar
• Shaw DM, Elger BS, Colledge F. What is a biobank? Differing definitions among biobank stakeholders. Clin Genet. 2014;85:223–227.
   Web of Science ®Google Scholar
• Morente MM, Fernández PL, de Alava E. Biobanking: old activity or young discipline. Semin Diagn Pathol. 2008;25:317–322.
   Web of Science ®Google Scholar
• Strong DM. The US Navy Tissue Bank: 50 years on the cutting edge. Cell Tissue Bank. 2000;1:9–16.
   Google Scholar
• Henderson GE, Cadigan RJ, Edwards TP, et al. Characterizing biobank organizations in the US: results from a national survey. Genome Med. 2013;5:3.
   PubMed Web of Science ®Google Scholar
• A comprehensive review of cancer-related biobanks in New South Wales, Oct 2009. Cancer Institute NSW Monograph. Available from: https://www.cancerinstitute.org.au/how-we-help/reports-and-publications/a-comprehensive-review-of-cancer-related-biobanks. Accessed November 2, 2016.
   Google Scholar
• Rush A, Christiansen JH, Farrell JP, et al. Biobank classification in an Australian setting. Biopreserv Biobank. 2015;13:212–218.
   Web of Science ®Google Scholar
• Louk K. Rethinking the ethics of human biomedical non-interventional research. In: Schildmann J, Sandow V, Rauprich O, Vollmann J, editors. Human Medical Research. Basel: Springer; 2012: Chapter 15, 175–184,
   Google Scholar
• Holmberg T, Schwennesen N, Webster A. Bio-objects and the bio-objectification process. Croatian Med J. 2011;52:240–242.
   Web of Science ®Google Scholar
• Tupasela A, Stephens N. The boom and bust cycle of biobanking – thinking through the life cycle of biobanks. Croatian Med J. 2013;54:501–503.
   PubMed Web of Science ®Google Scholar
• Stephens N, Dimond R. Unexpected tissue and the biobank that closed: an exploration of value and the momentariness of bio-objectification processes, Life Sci Soc Policy. 2015;11:14.
   PubMedGoogle Scholar
• Boeckhout M, Douglas CMW. Governing the research-care divide in clinical biobanking: Dutch perspective. Life Sci Soc Policy. 2015;11:7.
   Google Scholar
• Kirchgaessner S. Ethical questions raised in search for Sardinian centenarians’ secret. The Guardian. 2016 Aug 13. Available from: https://www.theguardian.com/world/2016/aug/12/ethical-questions-raised-in-search-for-sardinian-centenarians-secrets. Accessed November 2, 2016.
   Google Scholar
• Gibbons SMC, Kaye J. Governing genetic databases: collection, storage and use. Kings Law J. 2007;18:201–208.
   Google Scholar
• Knoppers BM, Hudson TJ. The art and science of biobanking. Hum Genet. 2011;130:329–332.
   Web of Science ®Google Scholar
• Henderson GE, Edwards TP, Cadigan RJ, et al. Stewardship practices of U.S. biobanks. Sci Transl Med. 2013;5:1–6.
   Web of Science ®Google Scholar
• Brenner J. Establish a transparent chain-of-custody to mitigate risk and ensure quality of specialized samples. Biopreserv Biobank. 2010;7:151–153.
   Web of Science ®Google Scholar
• Oosterhuis JW, Coebergh J, van Veen EB. Tumour banks, well-guarded treasures in the interest of patients. Nat Rev Cancer. 2003;3:73–77.
   PubMed Web of Science ®Google Scholar
• Hansson MG. Ethics and biobanks. Br J Cancer. 2009;100:8–12.
   PubMed Web of Science ®Google Scholar
• Morrell B, Lipworth W, Axler R, Kerridge I, Little M. Cancer as rubbish: donation of tumour tissue for research. Qual Health Res. 2011;21:75–81.
   PubMed Web of Science ®Google Scholar
• Pillai U, Phillips K, Wilkins G, et al. Factors that may influence the willingness of cancer patients to consent for biobanking. Biopreserv Biobank. 2014;12:409–413.
   Web of Science ®Google Scholar
• Mancini J, Pellegrini I, Viret F, et al. Consent for biobanking: assessing understanding and views of cancer patients. J Natl Cancer Inst. 2011;103:154–157.
   Google Scholar
• Porteri C, Pasqualetti P, Togni E, Parker M. Public’s attitudes on participation in a biobank for research: an Italian survey. BMC Med Ethics. 2014;15:81.
   Web of Science ®Google Scholar
• Wendler D. One-time general consent for research on biological samples. Br Med J. 2006;332:544–547.
   PubMed Web of Science ®Google Scholar
• Coebergh JWW, van Veen E-B, Vandenbroucke JP, van Diest P, Oosterhuis W. Opt out system for patient is optimal and endorsed in many countries. BMJ. 2006;332:665.
   Google Scholar
• Johnsson L, Hansson MG, Eriksson S, Helgesson G. Patients’ refusal to consent to storage and use of samples in Swedish biobanks: cross sectional study. BMJ. 2008;337:224–226.
   Google Scholar
• Laurie G. Consent for biobanking: lack of dissent when opting in doesn’t necessarily support ‘opt out’. BMJ. 2008;337:186–187.
   Google Scholar
• Hansson MG. The need to downregulate: a minimal ethics framework for biobank research. Methods Mol Biol. 2011;675:39–59.
   Google Scholar
• Gedye C, Fleming J. Forsaking cures for cancer: why are we discarding the tumour biospecimens of most patients? Med J Aust. 2016;204:297–298.
   Web of Science ®Google Scholar
• Holm S. Informed consent and the bio-banking of material from children. Genom Soc Policy. 2005;1:16–26.
   Google Scholar
• Hens K, Cassiman J-J, Nys H, Diericks K. Children, biobanks and the scope of parental consent. Eur J Hum Genet. 2011;19:735–739.
   PubMed Web of Science ®Google Scholar
• Rush A, Battisti R, Barton B, Catchpoole D. Opinions of young adults on re-consenting for biobanking. J Paediatrics. 2015;167:925–930.
   Web of Science ®Google Scholar
• Goldenberg AJ, Hull SC, Botkin JR, Wilfond BS. Pediatric biobanks: approaching informed consent for continuing research after children grow up. J Pediatrics. 2009;155:578–583.
   PubMed Web of Science ®Google Scholar
• Offit K. Personalized medicine: new genomics, old lessons. Hum Genet. 2011;130:3–14.
   PubMed Web of Science ®Google Scholar
• Knoppers BM, Avard D, Senecal K, Zawati MH along with the PG International Paediatrics Platform members. Return of whole-genome sequencing results in paediatric research: a statement of the P3G international paediatric platform. Eur J Hum Genet. 2014;22:3–5.
   PubMed Web of Science ®Google Scholar
• Bredenoord AL, van Delden JJM. Research ethics in genomic research: feedback of individual genetic data to research participants. In: Schildmann J, Sandow V, Rauprich O, Vollmann J, editors. Human Medical Research. Basil: Springer: 2012:127–135.
   Google Scholar
• National Statement on Ethical Conduct in Human Research 2007. National Health and Medical Research Council. Updated May 2015. Available from: https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/e72_national_statement_may_2015_150514_a.pdf. Accessed November 2, 2016.
   Google Scholar
• Zeps N, Bledsoe MJ, Managing the ethical issues of genomic research using pathology specimens. Clin Biochem Rev. 2015;36:21–27.
   Google Scholar
• Rush A, Spring K, Byrne JA. A critical review of cancer biobank practice in relation to biospecimen quality. Biophys Rev. 2015;7:369–378.
   PubMedGoogle Scholar
• Enroth S, Hallmans G, Grankvist K, Gyllensten U. Effects of long-term storage time and original sampling month on biobank plasma protein concentration. E Bio Medicine. 2016;12:309–314.
   Google Scholar
• Jones RJ, Boyce T, Fennell M, et al. The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers. Cancer Chemother Pharmacol. 2008;61:23–32.
   Web of Science ®Google Scholar
• Betsou F, Barnes R, Burke T, et al. Human biospecimens research: Experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev. 2009;18:1017–1025.
   PubMed Web of Science ®Google Scholar
• Betsou F, Lehmann S, Ashton G, et al. Standard preanalytical coding for biospecimens: defining the sample PREanalytical Code. Cancer Epidemiol Biomarkers Prev. 2010;19:1004–1011.
   PubMed Web of Science ®Google Scholar
• Lee D, Lee Y. The Korean National Research Resource Centre. Biopreserv Biobank. 2010;7:137–142.
   Web of Science ®Google Scholar
• Harris JR, Burton P, Knoppers BM, et al. Toward a roadmap in global biobanking for health. Eur J Hum Genet. 2012;20:1105–1111.
   PubMed Web of Science ®Google Scholar
• Cervo S, De Paoli P, Perin T, Canzonieri V, Steffan A. Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization. Int J Biol Markers. 2015;30:e243–e251.
   Web of Science ®Google Scholar
• Grizzle WE, Guner EW, Sexton KC, Bell WC. Quality management of biorepositories. Biopreserv Biobank. 2015;13:193–194.
   Web of Science ®Google Scholar
• Riegman PHJ, de Jong B, Daidone MG, et al. Optimizing sharing of hospital biobank samples. Sci Transl Med. 2015;7:297.
   Web of Science ®Google Scholar
• Vaught J, Rogers J, Carolin T, Compton C. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr. 2011;2011:24–31.
   Google Scholar
• Albert M, Bartlett J, Johnston RN, Schacter B, Watson P. Biobank bootstrapping: Is biobank sustainability possible through cost recovery? Biopreserv Biobank. 2014;12:374–380.
   Web of Science ®Google Scholar
• Chandras C, Weaver T, Zouberakis M, et al. Models for financial sustainability of biological databases and resources. Database. 2009;bap017:1–9.
   Google Scholar
• Parry-Jones A. Assessing the financial, operational and social sustainability of a biobank: The Wales Cancer Bank case study. Biopreserv Biobank. 2014;12:381–388.
   PubMed Web of Science ®Google Scholar
• Wilson GD, D’Angelo K, Pruetz BL, Geddes TJ, Larson DM, Akervall J. The challenge of sustaining a hospital-based biobank and core molecular laboratory: The Beaumont Experience. Biopreserv Biobank. 2014;12:306–311.
   Web of Science ®Google Scholar
• Warth R, Perren A. Construction of a business model to assure financial sustainability of biobanks. Biopreserv Biobank. 2014;12:389–394.
   Web of Science ®Google Scholar
• Rubinstein YR, Croft SC, Bartek R, et al. Creating a global rare disease patient registry linked to a rare disease biorepository database: Rare Disease-HUB (RD-HUB). Contemp Clin Trials. 2010;31:394–404.
   PubMed Web of Science ®Google Scholar
• Roazzi P, Benedetto CD, Bravo E, D’Agnolo G. Biobank networking: The European Network Initiative and the Italian Participation. Biopreserv Biobank. 2011;9:175–179.
   Web of Science ®Google Scholar
• Translational Cancer Research Centres NSW, Cancer Institute of NSW Website. Published Sept 2016. Available from: https://www.cancerinstitute.org.au/data-research/translating-research-into-practice/funded-centres. Accessed November 2, 2016.
   Google Scholar
• Colledge F, Elger B, Howard HC. A review of the barriers to sharing in biobanking. Biopreserv Biobank. 2013;11:339–346.
   PubMed Web of Science ®Google Scholar
• Zhou L, Catchpoole DR, Spanning the genomics era: the vital role of a single institution biorepository for rare disease research over a decade. Transl Paediatrics. 2015;4:93–106.
   Web of Science ®Google Scholar
• Hughes SE, Barnes RO, Watson PE. Biospecimen use in cancer research over two decades. Biopreserv Biobank. 2010;8:89–97.
   Web of Science ®Google Scholar
• Cole A, Cheah S, Dee S, et al. Biospecimen use correlates with emerging techniques in cancer research: impact on planning future biobanks. Biopreserv Biobank. 2012;10:518–525.
   Web of Science ®Google Scholar
• Braun L, Lesperance M, Mes-Massons A-M, Tsao MS, Watson PH. Individual investigator profiles of biospecimen use in cancer research. Biopreserv Biobank. 2014;12:192–198.
   Web of Science ®Google Scholar
• Wai CT. The closure of the national bio-bank in Singapore. Asia Pacific Biotech. 2012;16(4):40–44.
   Google Scholar
• Castillo_Pelayo T, Babinszky S, LeBlanc J, Watson PH. The importance of biobanking in cancer research. Biopreserv Biobank. 2015;13:172–177.
   Web of Science ®Google Scholar
• Cadigan RJ, Lassiter D, Haldeman K, Conlon I, Reavely E, Henderson GE. Neglected ethical issues in biobank management: results from a U.S. study. Life Sci Soc Policy. 2013;5:3.
   Google Scholar
• McIntyre P. Unlocking progress: why we need to change the culture of biobanking. Cancer World. 2016;72:46–50.
   Google Scholar
• Verlinden M, Nys H, Ectors N, Huys I. Access to biobanks: harmonization across biobank initiatives. Biopreserv Biobank. 2014;12:422.
   Web of Science ®Google Scholar
• Mascalzoni D, Dove ES, Rubinstein Y, et al. International charter of principles for sharing bio-specimens and data. Eur J Hum Genet. 2015;23:721–728.
   PubMed Web of Science ®Google Scholar
• Salman RA, Beller E, Kagan J, et al. Increasing value and reducing waste in biomedical research regulation and management. Lancet. 2014;383:176–185.
   PubMed Web of Science ®Google Scholar
• Woolf SH. The meaning of translational research and why it matters. JAMA. 2011;299:211–213.
   Google Scholar
• Charo A. Body or research – ownership and use of human tissue. N Engl J Med. 2006;355:1517–1519.
   Web of Science ®Google Scholar
• Taualii M, Davis EL, Braun KL, et al. Native Hawaiian views on biobanking. J Cancer Educ. 2014;29:570–576.
   Web of Science ®Google Scholar
• Terzic A, Waldman SA. Translational medicine: path to personalized and public health. Biomark Med. 2010;4:787–790.
   Web of Science ®Google Scholar
• Steinsbekk KS, Solberg B. Biobanks – when is re-consent necessary? Public Health Ethics. 2011;4:236–250.
   Web of Science ®Google Scholar
• Thompson M. Rubbish Theory. Oxford, UK: Oxford University Press; 1979.
   Google Scholar
• Haring RC, Henry WA, Hudson M, Rodriquez EM, Taualii M. Views on clinical trial recruitment, biospecimen collection, and cancer research: population science from landscapes of the Haudenosaunee (People of the Longhouse). J Cancer Educ. 2016 Epub July 9.
   Google Scholar
• Daley B, Cranley E. ‘Biorights’ rise: donors demand control of their samples. SciPol Website; October 2016. Available from: http://sciencepolicy.duke.edu/content/%E2%80%98biorights%E2%80%99-rise-donors-demand-control-their-samples. Accessed November 2, 2016.
   Google Scholar
• Hansson MG. Building on relationships of trust in biobank research. J Med Ethics. 2005;31:415–418.
   Web of Science ®Google Scholar
• Boeckhout M, Reuzel R, Zielhuis G. The donor as partner: How to involve patients and the public in the governance of biobanks and registries. BBMRI Biobank Services Netherland; 2014. Available from: www.bbmri.nl/wp-content/uploads/2015/10/guidelineeng_def.pdf. Accessed November 2, 2016.
   Google Scholar
• Kaye J. Embedding biobanks as tools for personalised medicine. Norsk Epidemiologi. 2012;21:169–175.
   Google Scholar
• Bevilacqua G, Bosman F, Dassesse T, et al. The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch. 2010;456:449–454.
   Web of Science ®Google Scholar
• Groenen PJTA, Blokx WAM, Diepenbroek C, et al. Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase. Histopathology. 2011;59:1–7.
   PubMed Web of Science ®Google Scholar
• Reed W, Jor S, Brugn R. How can clinical biobanks and patient information be adapted for research – establishing a hospital based data warehouse solution. Norsk Epidemiologi. 2012;21:191–194.
   Google Scholar
• Riegman PHJ, Dinjens WNM, Oosterhuis KJ. Biobanking for interdisciplinary clinical research. Pathobiology. 2007;74:239–244.
   PubMed Web of Science ®Google Scholar
• Cortés B, Schiffman M, Herrero R, et al. Establishment and operation of a biorepository for molecular epidemiologic studies in Costa Rica. Cancer Epidemiol Biomarkers Prev. 2010;19:916–922.
   PubMed Web of Science ®Google Scholar
• Knoppers BM. Consent to ‘personal’ genomics and privacy. EMBO Rep. 2010;11:416–419.
   PubMedGoogle Scholar
• Bellgard M, Beroud C, Parkinson K, et al. Dispelling myths about rare disease registry system development. Source Code Biol Med. 2013;8:21.
   PubMedGoogle Scholar